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Abstract The possible involvement of protein phosphatase in 
ceramide-mediated neural cell differentiation was investigated. 
Neuroblastoma Neuro2a cell differentiation induced by retinoic 
acid, or conditions causing an increase in cellular ceramide, was 
significantly inhibited by the serinelthreonine phosphatase 
inhibitor okadaic acid, at concentrations as low as 2.5 nM. A 
crude cytosolic preparation from Neuro2a cells was found to 
have a cation-independent protein phosphatase activity that was 
stimulated by ceramide in a dose-dependent manner. Short- and 
long-chain ceramides, but not sphingosine and related dihydro- 
derivatives, were active. Ceramide-activated protein phosphatase 
activity from Neuro2a cells was inhibited by 5 nM okadaic acid. 
The data indicate that a type 2A protein phosphatase is involved 
in ceramide-mediated differentiation of Neuro2a cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Ceramide, the N-acylated derivative of sphingosine, has 
emerged as a widespread biomodulator, produced by cells 
when stimulated with different agents. It is involved in the 
regulation of fundamental cellular processes, like growth, dif- 
ferentiation and programmed cell death [1-5]. Also cells of 
neural origin share ceramide as an intracellular mediator of 
the effects of specific stimuli, especially with regard to differ- 
entiation [6-8]. In fact, in neuroblastoma nd glioblastoma 
cell lines the administration of differentiating agents results 
in an increase in the cellular level of ceramide, which, in 
turn, appears to mediate their differentiation to, respectively, 
a neuron- [6,7] and an astrocyte-like phenotype [8]. In the 
same cells ceramide or ceramide analogs can mimick this ef- 
fect. In particular in murine Neuro2a neuroblastoma cells 
retinoic acid and serum removal induce a neuron-like differ- 
entiation that is characterized by a rapid and persistent in- 
crease in the cellular levels of ceramide [6]. Moreover, removal 
of the differentiating agents results in a lowering of the ceram- 
ide levels and a reversal of differentiation. Also the experimen- 
tal conditions that raise the cellular ceramide levels lead to 
stimulation of neurite outgrowth and growth inhibition in 
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neuroblastoma cells [6,7]. Further support for the role of ce- 
ramide in neuronal differentiation comes from primary cul- 
tures of cerebellar neurons where the cellular content of ce- 
ramide markedly increases during differentiation i culture [7]. 
Present-day knowledge of molecular mechanisms at the ba- 
sis of ceramide effects in cells are still limited. However one 
possibility appears to be the modulation of protein phospho- 
rylation. In fact ceramide has been demonstrated to activate a 
proline-directed protein kinase, a protein kinase C¢ isotype 
and a serine/threonine type 2A protein phosphatase [9 15]. 
In particular, a ceramide-activated type 2A protein phospha- 
tase has been reported to occur in rat brain and in glioblas- 
toma cells [11,12]. 
Thus, prompted by the li~ct that protein phosphorylation 
appears to play a crucial role in neuroblastoma cell differen- 
tiation [16,17], we investigated the possible role of protein 
phosphorylation in the ceramide-mediated differentiation of 
Neuro2a cells. The data obtained in this work strongly sug- 
gest that a cytosolic type 2A protein phosphatase, specifically 
activated by ceramide, is involved in the regulation of Neu- 
ro2a cell differentiation. 
2. Materials and methods 
2.1. Chemicals 
Reagents were of the highest purity available and solvents were 
redistilled before use. DMEM, FCS (heat-inactivated before use), bo- 
vine serum albumin, RA, PMSF, leupeptin, pepStatin A, bestatin, t> 
erythro-sphingosine, ot.-threo-dihydrosphingosine~ C18-Cer, ceramide 
from bovine brain sphingomyelin, C16-dihydrocer, ATP, histone type 
Ill-S, were from Sigma (St. Louis, MO, USA). C2-dihydrocer and 
protein kinase C from rat brain were from Calbiochem (La Jolla. 
CA, USA). C2-Cer was from Matreya Inc. (Pleasant Gap, PA, 
USA). Okadaic acid sodium salt was from LC Laboratories (Woburn. 
MA. USA). Phosphatidylserine was from BDH (Poole, UK). 
[y-:~eP]ATP (30 Ci/mmol) was from Amersham International (Amer- 
sham, Buckingamshire, UK). 
2.2. Cell culture 
Murine neuroblastoma Neuro2a cells (CCL-131, American Cell 
Type Culture Collection) were cultured in plastic dishes or flasks in 
DMEM supplemented with 10% FCS, 4 mM L-glutamine, 1 mM 
sodium pyruvate, 100 units/mL penicillin G andl 100 Bg/mL strepto- 
mycin sulphate at 37°C in a humidified atmosphere of 5% CO~ and 
5% air. 
2.3. Cell differentiation and okadaic acM treatment in cultured cells 
Neuro2a cells were plated at 3 x 103/cm 2 in 35-mm Falcon dishes 
and grown for 2 days in 10% FCS-DMEM; to induce neuronal differ- 
entiation, the cells were rinsed with DMEM containing 2% FCS and 
incubated in the same medium (1 mL/dish) with 20 oM RA [18] or 2 
5 /.tM sphingoid molecules [6] for different imes, up to 48 h. In some 
plates okadaic acid (OA), a cell-permeable s ri~e/threonine protein 
phosphatase inhibitor, (2.5-10 nM in 0.05% DMSO, final concentra- 
tion) was added to the culture medium [19 21], during treatment with 
inducers. Cell viability and neurite outgrowth evaluation were accom- 
plished by phase-contrast microscopy as previously described [6]. 
0014-5793/97/$17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P I IS0014-5793(97)00981-2  
476 A. Prinetti et al./FEBS Letters 414 (1997) 475-479 
2.4. Cell fractionation 
Neuro2a cells were cultured in 75 cm 2 flask, in supplemented 
DMEM. 2× 107 cells from confluent cultures (approximately 10 mg 
of cellular protein) were rinsed with phosphate-buffered saline, resus- 
pended in 2 mL of homogenization buffer (20 mM Tris-Cl pH 7.4, 
1 mM EDTA, 0.1 mM EGTA, 0.5 mM DTT, 0.25 mM PMSF, 1 gg/ 
mL leupeptin, 1gg/mL pepstatin A, 10 gg/mL bestatin) and disrupted 
by sonication. Cell homogenate was centrifuged at 700 × g for 10 min 
at 4°C to remove nuclei and cell debris. The supernatant was centri- 
fuged at 100 000 x g for 1 h at 4°C and the resulting cytosolic fraction 
was used fresh or stored in aliquots at -80°C. Protein concentration 
was determined [22], using bovine serum albumin as standard. 
2.5. Preparation of [s2 P]phosphohistone 
[32P]phosphohistone was prepared as previously described [11], ex- 
cept that a commercially available rat brain protein kinase C prepa- 
ration was used: 1U/mL of the enzyme was incubated in the presence 
of 2 mg/mL histone type IIIS and 12.5 gM ['#32p]ATP (20 Ci/mmol). 
A typical preparation of [3ZP]phosphohistone contained 4-6 nmol of 
Pi per mg protein. 
2.6. Phosphatase assay 
Dephosphorylation reactions were performed using 0.5 /aM 
[32p]phosphohistone as substrate and 10 /ag/mL of crude cytosolic 
protein, as described by Dobrowsky and Hannun [11]. Incubations 
were performed at 37°C for 5 min. In the used conditions, protein 
phosphatase activity from Neuro2a cells was linear in the range 3-30 
I.tg/ml up to 15 min incubation at 37°C. 
C2-Cer, sphingosine and their dihydroderivatives w re prepared in 
absolute thanol immediately before use and used at 0.1-25 p.M (0.5% 
final ethanol concentration). C18-Cer, Cer and Cl6-dihydrocer were 
dissolved in ethanol/dodecane 98/2 (v/v) according to Ji et al. [23] and 
administered at 0.1-25 gM in 0.5% ethanol/0.01% dodecane (final 
concentrations) These conditions allowed a complete solubilization 
of ceramides in the dephosphorylation assay. OA, delivered from a 
stock solution in DMSO (final DMSO concentration never exceeding 
0.05%), was added at 5 nM or 1 gM, final concentration, i  order to 
separately determine protein phosphatase 1 (PP1) and 2A (PP2A) 
[19,24]. PP1 activity was calculated as the difference between protein 
phosphatase activity measured at 5 nM and 1 /aM OA; PP2A activity 
as the difference between total protein phosphatase activity and that 
measured at 5 nM OA [19]. Ethanol, dodecane or DMSO at the 
utilized concentrations had no effect on enzyme activity. 
3. Results 
3.1. Effect of  OA on neurite outgrowth in Neuro2a cells 
In the first set of experiments we investigated the possible 
role of protein phosphatases in Neuro2a differentiation. For 
this purpose Neuro2a cell differentiation was induced by treat- 
ment with RA or Cer in the presence of the serine/threonine 
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Fig. 1. Effect of okadaic acid on Neuro2a differentiation. Neuro2a cells were treated with 20 gM retinoic acid (A and B) or 5 laM ceramide (C 
and D) in the absence (A and C) or presence (B and D) of 5 nM okadaic acid for 24 h. 
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Fig. 2. Effect of okadaic acid on ceramide-induced Neuro2a differ- 
entiation. Neuro2a cells were treated with 5 nM (upper panel) or 
different concentrations (lower panel) of okadaic acid (OA) in the 
absence (Control), or presence of various sphingoids (2 IaM) for 24 
h. The extension of neurite-like processes was evaluated and quanti- 
fied as described in Section 2. Data are the mean of three experi- 
ments in duplicate, SD. never exceeding 15% of the mean. Cer, cer- 
amide from bovine brain sphingomyelin; C2-Cer, C2-ceramide; Sph, 
sphingosine. 
phosphatase inhibitor OA. In agreement with previous reports 
[6,18] Neuro2a cells extended neurites in response to RA (Fig. 
lA) or ceramide (Fig. 1C). After 24 h treatment cells bearing 
neurites longer than twice the cell body diameter [6] accounted 
for 71.9+_8.3% (mean + S.D.) in the presence of 20 gM RA 
and 61.2 +- 7.0% for 5 gM Cer. In the presence of 5 nM OA 
there was no neuritogenic effect due to RA (Fig. 1B) and Cer 
(Fig. ID). As shown in Fig. 2 (upper part), the neuritogenic 
effect of C2-Cer or sphingosine was also impaired by 5 nM 
OA. The effect of different concentrations of OA on Cer-in- 
duced differentiation was then studied (Fig. 2, lower part). At 
2.5 nM OA, neurite bearing cells were markedly reduced 
(46.7% of cells without OA) and at 5 10 nM, the neuritogenic 
effect of Cer was completely reversed. In cultured Neuro2a 
cells, 2.5-10 nM OA alone had little or no effect on cell 
viability and morphology for periods of up to 48 h. 
3.2. Effect of ceramide on cytosolic protein phosphatase activity 
in Neuro2a cells 
Further experiments were performed to evaluate the possi- 
ble presence of a ceramide-sensitive protein phosphatase in 
Neuro2a cells. For this purpose the cation-independent pro- 
tein phosphatase activity was measured in a crude cytosolic 
preparation from Neuro2a cells using [32p]phosphohistone as 
substrate. The early experiments were performed with the 
short-chain analogue C2-Cer. As shown in Fig. 3 (upper 
part), C2-Cer increased the cytosolic protein phosphatase ac- 
tivity of the Neuro2a cells in a dose-dependent fashion, stim- 
ulation being detectable at 1 25 gM. At the same concentra- 
tions, also C18-Cer and Cer from bovine brain sphingomyelin 
(containing primarily stearic and nervonic acids) were effective 
(Fig. 3, middle and lower part). 
3.3. Spec(fici O, o/ceramide ffect on Neuro2a cvtosolic protein 
phosphatase activi O, 
To evaluate the specificity of Cer on protein phosphatase 
stimulation the effect of different molecules tructurally closely 
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Fig. 3. Effect of ceramide on cytosotic protein phosphatase ctivity 
in Neuro2a cells. Phosphatase activity was determined toward 
[32p]phosphohistone III-S in a cytosolic fraction from Neuro2a cells 
in the absence or presence of different concentrations of C2-ceram- 
ide (C2-Cer, upper part) or Cl8-ceramide (C18-Cer, middle part) or 
ceramide from bovine brain sphingomyelin (Cer, lower part). Data 
are obtained alter subtraction of the activity measured in the ab- 
sence of ceramide. Basal activity was 706_+ 51 pmol Pi/min per mg 
protein. Data are the mean values of two experiments in triplicate, 
S.D. never exceeding 12% of the mean. 
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Fig. 4. Effect of ceramides on protein phosphatase type 1 (PP1) and 
type 2A (PP2A) from Neuro2a cells. Protein phosphatase activity 
was evaluated in a cytosolic fraction from Neuro2a cells in the pres- 
ence of 25 ~M of different ceramides as described in Section 2. PP1 
activity was calculated by the difference between 5 nM OA-residual 
activity and 1 ~tM OA residual activity and PP2A by the difference 
between total cytosolic protein phosphatase activity and the residual 
activity in the presence of 5 nM OA. Data are expressed as percent 
of activity in the absence of ceramides and are the mean of three 
experiments in triplicate. Control activity was 0.394 and 0.410 nmol 
Pi/min per mg protein for PP1 and PP2A, respectively. 
related to ceramide was investigated. Under experimental con- 
ditions where C2-Cer or long-chain ceramides were active, C2- 
or C16-dihydroceramide, sphingosine and racemic threo-dihy- 
drosphingosine had no effect on the Neuro2a cytosolic protein 
phosphatase activity (Table 1). 
3.4. Lffect of OA on protein phosphatase activity in Neuro2a 
cells 
To evaluate whether a specific phosphatase type could be 
responsible for ceramide-stimulated activity, protein phospha- 
tase activity was measured in the presence of different OA 
concentrations. It is known that OA, a complex fatty acid 
polyether, completely inhibits PP2A at 1 5 nM, while higher 
concentrations are needed to inhibit PP1 [19]. In a cytosolic 
fraction from Neuro2a cells, protein phosphatase activity 
(0.815 pmol Pi/min per mg protein) was reduced to approx- 
imately one-half the total by 5 nM OA (0.405 pmol Pi/min per 
mg protein) and was almost completely abolished by 1 /aM 
OA (0.011 pmol Pi/min per mg protein). Thus, in the exper- 
imental conditions used, the PPI and PP2A activities each 
contributed about 50% of the total cytosolic protein phospha- 
tase. 
The effect of 5 nM and 1 ~tM OA on Cer-activated protein 
phosphatase allowed the identification of the type of activated 
phosphatase. As shown in Fig. 4, 25 ~tM C2-Cer and C18-Cer, 
as well as Cer from bovine brain sphingomyelin, significantly 
increase PP2A activity in the cytosol of Neuro2a cells but had 
no effect on PP1. 
4. Discussion 
Previous studies in our laboratory have demonstrated that 
Cer plays a mediator role in Neuro2a differentiation [6,7] and 
this prompted us to carry out further investigations. The data 
from the present work demonstrate the involvement of an 
OA-sensitive pathway in the Cer-mediated differentiation of
Neuro2a cells. In fact, the neuritogenic effects of RA (which 
induces Cer increase), as well as of exogenous Cer, are 
strongly reduced by treating cells with OA. OA concentrations 
as low as 2.5 nM were effective and in the presence of 5 nM 
OA, neurite extension induced by either RA or ceramide or 
sphingosine was completely inhibited. Thus, the activity of a 
type 1 and/or 2A serine/threonine protein phosphatase ap- 
pears to be involved in ceramide-mediated Neuro2a cell differ- 
entiation. Despite the difficulty in achieving selective PP1 or 
PP2A inhibition in intact cells [19-21], the efficacy of low 
nanomolar concentrations of OA in the inhibition of Neuro2a 
cell differentiation suggests that PP2A rather than PP1 is in- 
volved in this phenomenon. These data are in agreement with 
other studies that demonstrate an OA inhibitory effect in oth- 
er models of neuronal differentiation [21,25]. Direct proof of 
the existence of a type 2A ceramide-activated protein phos- 
phatase in Neuro2a cells was found using a cell-free system, 
i.e. a cytosolic extract from these cells. Even in the micro- 
molar range ceramide activates a cytosolic protein phospha- 
tase in a dose-dependent manner. Furthermore both C2-Cer 
and natural occurring long-chain ceramides have similar po- 
tency. The ceramide-activated protein phosphatase activity 
was sensitive to OA inhibition and was completely inhibited 
in the presence of 5 nM OA. These results upport he notion 
that the involved protein phosphatase b longs to the type 2A. 
Stimulation of cytosolic protein phosphatase by Cer was 
specific. In fact molecules tructurally related to Cer but lack- 
ing the double bond between C4 and C5 of the sphingoid base 
(C2-, C16-dihydrocer and DL-threo-dihydrosphingosine) w re 
Table 1 
Effect of different sphingoid molecules on cytosolic protein phosphatase activity in Neuro2a cells 
Sphingoid molecule Protein phosphatase activity (nmol/min per mg protein) % 
None 0.815 + 0.030 100 
Ceramide 1.056 + 0.063"* 130 
C2-dihydroceramide 0.798 + 0.180 98 
C 18-ceramide 1.055 + 0.047** 130 
C 16-dihydroceramide 0.805 + 0.034 99 
Sphingosine 0.802 + 0.005 98 
Threo-dihydrosphingosine 0.851 + 0.015 104 
Neuro2a cytosolic protein phosphatase activity was evaluated (see Section 2 in the absence (control) or presence of 25 l.tM sphingoid molecule. 
Data are expressed asnmol Pi/min per mg protein and are the mean_+ S.D. of 3 experiments in triplicate. **P < 0.01. 
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ineffective. It is noteworthy that the same specificity was ob- 
served in the effect on Neuro2a cell differentiation [6]. On the 
other hand sphingosine, which is able to induce neuritogenesis 
when administered to Neuro2a cells, had no effect on the 
activity of protein phosphatases in vitro. This apparent dis- 
crepancy can be explained by the fact that in Neuro2a cells 
sphingosine, when administered to cells at neuritogenic doses, 
is rapidly and efficiently converted to ceramide [6] which is the 
true effector. 
Taken together, these results provide evidence of intracel- 
lular targets that mediate Cer-induced neuronal differentia- 
tion, and indicate a specific activation of a cytosolic type 
2A protein phosphatase. This is in agreement with the evi- 
dence that the phosphorylation control of key cellular pro- 
teins is a crucial event in neural differentiation. In fact com- 
pounds activating cyclic AMP-dependent PKA (such as 
cAMP-analogues or phosphodiesterase inhibitors) [17,26], or 
inhibiting/down-regulating PKC [16,27,28] are able to induce 
neurite extension an the arrest of cell proliferation in Neuro2a 
cells. The present work demonstrates that a signal-mediated 
dephosphorylation pathway involving type 2A protein phos- 
phatase also contributes to this regulation. Future research 
will be aimed at identifying the protein target(s) of type 2A 
protein-phosphatase that is(are) instrumental to Neuro2a cell 
differentiation. 
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